Analyzing MRI to predict aggressive prostate cancer in African American men
Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
This study is looking to make it easier to spot aggressive prostate cancer in African American men by using advanced MRI techniques that take into account specific traits related to race, helping doctors get better and more accurate results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11065578 on NIH RePORTER |
What this research studies
This research focuses on improving the detection of aggressive prostate cancer in African American men by utilizing advanced MRI techniques. It aims to enhance the current imaging interpretation system, known as PI-RADS, by incorporating racially associated characteristics that affect MRI results. The study will analyze differences in tumor detection rates between African American and Caucasian men, particularly in the transition zone of the prostate. By developing a portable perfusion phantom to standardize measurements, the research seeks to improve the accuracy and reliability of MRI assessments across different medical facilities.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American men who are at risk for or have been diagnosed with prostate cancer.
Not a fit: Patients who are not African American or those without prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate prostate cancer diagnoses for African American men, potentially improving treatment outcomes.
How similar studies have performed: Previous research has indicated that incorporating racial factors into medical imaging can improve diagnostic accuracy, suggesting a promising avenue for this approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Sung, Kyung Hyun — University of California Los Angeles
- Study coordinator: Sung, Kyung Hyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.